Related Experiment Video
Updated: Nov 19, 2025

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells
Claire D James1, Siddharth Saini2, Fatmata Sesay2
1Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University (VCU), Richmond, VA 23298, USA.
Abstract:
High-risk (HR) human papillomaviruses are known causative agents in 5% of human cancers including cervical, ano-genital and head and neck carcinomas. In part, HR-HPV causes cancer by targeting host-cell tumor suppressors including retinoblastoma protein (pRb) and RB-like proteins p107 and p130. HR-HPV E7 uses a LxCxE motif to bind RB proteins, impairing their ability to control cell-cycle dependent transcription. E7 disrupts DREAM (Dimerization partner, RB-like, E2F and MuvB), a transcriptional repressor complex that can include p130 or p107, but not pRb, which regulates genes required for cell cycle progression. However, it is not known whether disruption of DREAM plays a significant role in HPV-driven tumorigenesis. In the DREAM complex, LIN52 is an adaptor that binds directly to p130 via an E7-like LxSxE motif. Replacement of the LxSxE sequence in LIN52 with LxCxE (LIN52-S20C) increases p130 binding and partially restores DREAM assembly in HPV-positive keratinocytes and human cervical cancer cells, inhibiting proliferation. Our findings demonstrate that disruption of the DREAM complex by E7 is an important process promoting cellular proliferation by HR-HPV. Restoration of the DREAM complex in HR-HPV positive cells may therefore have therapeutic benefits in HR-HPV positive cancers.
Insights
High-risk human papillomaviruses (HR-HPV) promote cancer by disrupting the DREAM complex. Restoring this complex in HR-HPV-positive cells inhibits proliferation, offering a potential therapeutic strategy for HPV-driven cancers.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- High-risk human papillomaviruses (HR-HPV) are linked to 5% of human cancers, including cervical, ano-genital, and head and neck carcinomas.
- HR-HPV oncoproteins, particularly E7, target host tumor suppressors like retinoblastoma protein (pRb) and its relatives (p107, p130) to drive cancer progression.
- The E7 protein's LxCxE motif binds RB proteins, disrupting cell-cycle control and the DREAM transcriptional repressor complex.
Purpose of the Study:
- To investigate the role of DREAM complex disruption in HR-HPV-driven tumorigenesis.
- To explore the therapeutic potential of restoring DREAM complex function in HR-HPV-positive cancers.
Main Methods:
- Studied the interaction between the LIN52 adaptor protein within the DREAM complex and p130.
- Engineered a LIN52 mutant (LIN52-S20C) with an altered motif to enhance binding to p130.
- Assessed the impact of this mutation on DREAM complex assembly and cell proliferation in HPV-positive keratinocytes and cervical cancer cells.
Main Results:
- LIN52 binds p130 via an E7-like LxSxE motif; altering this to LxCxE (LIN52-S20C) enhances p130 binding.
- LIN52-S20C partially restored DREAM complex assembly in HR-HPV-positive cells.
- Restoration of the DREAM complex led to inhibited proliferation in these cancer cells.
Conclusions:
- Disruption of the DREAM complex by HR-HPV E7 is a key mechanism promoting cellular proliferation in HR-HPV-driven cancers.
- Restoring the DREAM complex in HR-HPV-positive cells demonstrates therapeutic potential for treating associated cancers.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

